EUVIMEDEUVIMED entdecken
Crossref

Development of A Personalized Treatment Algorithm for Pediatric Atopic Dermatitis Based on Molecular Allergy Diagnostics

Rasikova Gulmira Rustamovna, Khodjayeva Shakhzoda Komronovna

International Journal of Medical Science and Public Health Research · 01.04.2026 · 7 (4) · 19-23

DOI: 10.37547/ijmsphr/volume07issue04-04 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Medical Science and Public Health Research, online erschienen am 01.04.2026. Verfasst von Rasikova Gulmira Rustamovna und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Atopic dermatitis is one of the most common chronic inflammatory skin diseases in children, characterized by early onset, recurrent course, and significant impact on quality of life. The heterogeneity of clinical manifestations and allergen sensitization profiles makes standard treatment approaches insufficiently effective. Recent advances in molecular allergy diagnostics, including component-resolved diagnostics, allow identification of individual allergen sensitization patterns and support personalized treatment strategies. However, the development of personalized treatment algorithms based on molecular allergy diagnostics in children with atopic dermatitis remains insufficiently studied.

Aim

To develop a personalized treatment algorithm for children with atopic dermatitis based on molecular allergy diagnostics using Phadia 200 (ImmunoCAP) and MADx ALEX platforms. Materials and Methods. This prospective study will be conducted at the Republican Specialized Scientific-Practical Allergology Center between 2023 and 2026. A total of 200 children aged 3–18 years diagnosed with atopic dermatitis will be included. Clinical assessment will include dermatological examination, allergic history evaluation, and disease severity assessment using the SCORAD index. Laboratory investigations will include complete blood count, eosinophil count, and total IgE measurement. Molecular allergy diagnostics will be performed using Phadia 200 (ImmunoCAP) and MADx ALEX platforms to determine individual allergen sensitization profiles. Personalized treatment strategies will be developed based on obtained results. Statistical analysis will be performed using SPSS software, with p

Zitieren

APA

Rustamovna, R. G., & Komronovna, K. S. (2026). Development of A Personalized Treatment Algorithm for Pediatric Atopic Dermatitis Based on Molecular Allergy Diagnostics. International Journal of Medical Science and Public Health Research, 7(4), 19-23. https://doi.org/10.37547/ijmsphr/volume07issue04-04

Vancouver

Rustamovna RG, Komronovna KS. Development of A Personalized Treatment Algorithm for Pediatric Atopic Dermatitis Based on Molecular Allergy Diagnostics. International Journal of Medical Science and Public Health Research. 2026;7(4):19-23. doi:10.37547/ijmsphr/volume07issue04-04

BibTeX
@article{Rustamovna2026,
  author = {Rustamovna, Rasikova Gulmira and Komronovna, Khodjayeva Shakhzoda},
  title = {Development of A Personalized Treatment Algorithm for Pediatric Atopic Dermatitis Based on Molecular Allergy Diagnostics},
  journal = {International Journal of Medical Science and Public Health Research},
  year = {2026},
  volume = {7},
  number = {4},
  pages = {19--23},
  doi = {10.37547/ijmsphr/volume07issue04-04}
}
Kostenlos starten →